A multicenter study of 167 lung cancer patients found that persistent emotional distress spanning neoadjuvant therapy through surgery independently tracks with worse overall survival and progression-free survival. The work adds patient-reported outcomes to the set of prognostic factors clinicians consider during intensive cancer treatment phases. The results align with a broader move toward integrating psychosocial measures into oncology risk models, though the study design does not establish causality.